Abstract
Introduction Mesenchymal stem cells (MSCs)-based therapies are becoming backbone for the regenerative medicine. Multiple clinical studies confirm the safety of allogenic and autologous human MSCs for treatment of human diseases [1,2] MSCs are multipotent, non-hematopoietic stem cells with anti-inflammatory, immunomodulatory and regenerative properties, and are explored for their therapeutic potential in
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: journal of Regenerative Medicine and Tissue Engineering
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
